Keynote Speakers

Session 1 “Viral epidemiology, evolution & genetics”

Keynote Speaker : Dr. Gustavo Palacios (Icahn School of Medicine at Mount Sinai, USA)
Presentation Title
: How Andes Virus Strain Epuyén Spread: The quest to unravel the Determinants of Human-to-Human Transmission during the Largest Hantavirus Pulmonary Syndrome Outbreak
Dr. Gustavo Palacios is the professor at the Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, USA. He earned the Philosophy of Doctor (Ph.D.) at the School of Pharmacy and Biochemistry, Universidad de Buenos Aires, Buenos Aires, Argentina. Dr. Palacios focuses on infectious diseases and bio-preparedness against any serious threat that unknown viruses pose to human health.

Session 2 “Replication, transcription, translation, & assembly”

Keynote Speaker : Dr. Eva Mittler (Albert Einstein College of Medicine, USA)
Presentation Title : Structural and mechanistic basis of neutralization by a pan-hantavirus protective human antibody
Dr. Eva Mittler is the research assistant professor at the Department of Microbiology & Immunology, Albert Einstein College of Medicine, New York, USA. She earned the Philosophy of Doctor (Ph.D.) at the Institute of Virology, Philipps University Marburg and the Center for Biological Safety, Robert-Koch Institute, Berlin, Germany. Dr. Mittler has had interests in investigating the mechanism of viral entry and therapeutic antibodies against emerging zoonotic viruses including hantaviruses and filoviruses.

Session 3 “Immune responses & pathogenesis”

Keynote Speaker : Dr. Jonas Klingström (Karolinska Institutet, Sweden)
Presentation Title : Hantavirus-infection lead to massive immune activation - but what is good and what is bad?
Dr. Jonas Klingström is the professor at the Division of Molecular Medicine and Virology, Department of Biomedical and Clinical Sciences, Linköping University and the group leader at the Center for Infectious Medicine (CIM), Department of Medicine Huddinge, Karolinska Institutet, Sweden. He earned the Philosophy of Doctor (Ph.D.) at the Experimental Medicine, Karolinska Institutet, Sweden. Dr. Klingström focuses on the mechanisms behind hantavirus pathogenesis, the acute and long-term clinical consequences of hantavirus-infection, and the development of specific treatment of HFRS patients.

Session 4 “Vaccines, therapeutics & clinical aspects”

Keynote Speaker : Dr. Jay W. Hooper (United States Army Medical Research Institute of Infectious Diseases, USA)
Presentation Title : Hantavirus Nucleic Acid Vaccines and Their Use in Antibody-based Medical Countermeasure Development
Dr. Jay W. Hooper is the Chief at the Molecular Virology Branch, Virology Division at the United States Army Medical Research Institute of Infectious Diseases. Dr. Hooper received a B.A. in Biology from Colby College in 1986 and a Ph.D. in Virology from Harvard University in 1995. His awards include the C. J. Peters Award for unfailing dedication to protecting the health and well-being of the U.S. Armed Forces. Dr. Hooper is an expert in DNA vaccine technology and the use of this technology to develop both active vaccines and passive (antibody-based) medical countermeasures.

Session 5 “Diagnosis & emerging hantaviruses”

Keynote Speaker : Dr. Colleen B. Jonsson (University of Tennessee, USA)
Presentation Title : Advancements, challenges, and gaps in surveillance of hantaviruses in wildlife
Dr. Colleen B. Jonsson is a Professor, the Harriet Van Vleet Chair of Excellence in Virology, Director of the Regional Biocontainment Laboratory, and Director of the Institute for the Study of Host-Pathogen Systems at the University of Tennessee Health Sciences Center (UTHSC) in Memphis. She earned the Philosophy of Doctor (Ph.D.) at the Department of Biochemistry, Purdue University, USA. Dr. Jonsson’s laboratory has studied the ecological and evolutionary relationships of the hantaviruses in rodents in Paraguay since 2003. The long terms goals of her research have been to define ecological factors that contribute to the spread of the virus in reservoir rodents and spillover into non-reservoir rodents in nature. She is also interested in the intra- and interhost diversity of this virus in natural and disturbed ecosystems and the nature of the viral populations that transmit and persist.